Arnold H. Horwitz

2.4k total citations
38 papers, 1.9k citations indexed

About

Arnold H. Horwitz is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Arnold H. Horwitz has authored 38 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 18 papers in Immunology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Arnold H. Horwitz's work include Immune Response and Inflammation (13 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Antimicrobial Peptides and Activities (9 papers). Arnold H. Horwitz is often cited by papers focused on Immune Response and Inflammation (13 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Antimicrobial Peptides and Activities (9 papers). Arnold H. Horwitz collaborates with scholars based in United States, Australia and Slovakia. Arnold H. Horwitz's co-authors include Marc Better, Chun‐Wei Chang, Randy Robinson, Georgia Theofan, Lynn S. Grinna, Peter Elsbach, Jerrold Weiss, Hélène Gazzano-Santoro, J B Parent and Gary Wilcox and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Arnold H. Horwitz

37 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arnold H. Horwitz United States 21 1.1k 812 626 341 222 38 1.9k
Michael D.P. Boyle United States 28 699 0.7× 567 0.7× 344 0.5× 135 0.4× 163 0.7× 103 2.4k
Margaret Goodall United Kingdom 31 1.3k 1.3× 1.7k 2.1× 1.2k 1.8× 79 0.2× 199 0.9× 76 3.6k
Ugo D’Oro Italy 31 1.1k 1.0× 1.6k 1.9× 248 0.4× 256 0.8× 104 0.5× 56 2.9k
Roman Halter Germany 18 637 0.6× 182 0.2× 140 0.2× 282 0.8× 523 2.4× 43 1.4k
Toshiko Yamamoto Japan 26 971 0.9× 1.6k 2.0× 159 0.3× 228 0.7× 150 0.7× 56 2.5k
E J Brown United States 24 424 0.4× 974 1.2× 254 0.4× 258 0.8× 160 0.7× 37 1.9k
Ilka Hoof Denmark 20 1.6k 1.5× 997 1.2× 432 0.7× 78 0.2× 94 0.4× 37 2.4k
J P Tite United Kingdom 31 741 0.7× 2.2k 2.8× 647 1.0× 115 0.3× 206 0.9× 75 3.4k
Hélène Gazzano-Santoro United States 13 685 0.7× 676 0.8× 572 0.9× 201 0.6× 64 0.3× 19 1.3k
J Parkkinen Finland 21 744 0.7× 258 0.3× 121 0.2× 172 0.5× 297 1.3× 29 2.0k

Countries citing papers authored by Arnold H. Horwitz

Since Specialization
Citations

This map shows the geographic impact of Arnold H. Horwitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnold H. Horwitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnold H. Horwitz more than expected).

Fields of papers citing papers by Arnold H. Horwitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnold H. Horwitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnold H. Horwitz. The network helps show where Arnold H. Horwitz may publish in the future.

Co-authorship network of co-authors of Arnold H. Horwitz

This figure shows the co-authorship network connecting the top 25 collaborators of Arnold H. Horwitz. A scholar is included among the top collaborators of Arnold H. Horwitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnold H. Horwitz. Arnold H. Horwitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tomic, Milan T., et al.. (2018). Antibody engineering to improve manufacturability. Protein Expression and Purification. 149. 75–83. 9 indexed citations
2.
Cotter, Robyn, et al.. (2013). Functional premature polyadenylation signals and aberrant splicing within a recombinant protein coding sequence limit expression. Protein Expression and Purification. 92(1). 14–20. 3 indexed citations
3.
Tomic, Milan T., Carlos A. García, Jianlong Lou, et al.. (2013). Recombinant monoclonal-antibody-based antitoxins for treatment of types A, B, and E botulism. Toxicon. 68. 99–100.
4.
Levy, Ronald, David Bohmann, Hassan Issafras, et al.. (2013). Enhancement of antibody fragment secretion into the Escherichia coli periplasm by co-expression with the peptidyl prolyl isomerase, FkpA, in the cytoplasm. Journal of Immunological Methods. 394(1-2). 10–21. 28 indexed citations
5.
Owyang, Alexander M., Hassan Issafras, John Corbin, et al.. (2011). XOMA 052, a potent, high-affinity monoclonal antibody for the treatment of IL-1β-mediated diseases. mAbs. 3(1). 49–60. 59 indexed citations
6.
Pryer, Nancy, Victoria Sung, Ursula Jeffry, et al.. (2009). Abstract #DDT02-2: MCS110: a monoclonal antibody with potent neutralizing activity against macrophage colony-stimulating factor for the treatment of tumor-induced osteolysis. Cancer Research. 69. 1 indexed citations
7.
Horwitz, Arnold H., W. S. Ammons, Robert J. Bauer, et al.. (2004). rBPI(10–193) is secreted by CHO cells and retains the activity of rBPI<SUB>21</SUB>. Journal of Endotoxin Research. 10(2). 97–106. 1 indexed citations
8.
Horwitz, Arnold H., et al.. (2000). Inclusion of S-Sepharose Beads in the Culture Medium Significantly Improves Recovery of Secreted rBPI21 from Transfected CHO-K1 Cells. Protein Expression and Purification. 18(1). 77–85. 7 indexed citations
9.
Wu, Hsiu‐Mei, Robert E. Williams, R. Little, et al.. (1997). Biochemical Characterization of Recombinant Fusions of Lipopolysaccharide Binding Protein and Bactericidal/Permeability-increasing Protein. Journal of Biological Chemistry. 272(4). 2149–2155. 54 indexed citations
10.
Horwitz, Arnold H., Richard Williams, & Grzegorz S. Nowakowski. (1995). Human lipopolysaccharide-binding protein potentiates bactericidal activity of human bactericidal/permeability-increasing protein. Infection and Immunity. 63(2). 522–527. 15 indexed citations
11.
Studnicka, Gary M., et al.. (1994). Human-engineered monoclonal antibodies retain full specific binding activity by preserving non-CDR complementarity-modulating residues. Protein Engineering Design and Selection. 7(6). 805–814. 40 indexed citations
12.
Horwitz, Arnold H., Rossana Nadell, Frank Preugschat, & Marc Better. (1994). Chimeric immunoglobulin light chains are secreted at different levels: Influence of framework-1 amino acids. Molecular Immunology. 31(9). 683–692. 10 indexed citations
13.
Gazzano-Santoro, Hélène, Károly Mészáros, C Birr, et al.. (1994). Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria. Infection and Immunity. 62(4). 1185–1191. 72 indexed citations
14.
Ammons, W. S., Arnold H. Horwitz, Lynn S. Grinna, et al.. (1993). Protective Effect of a Recombinant Amino-Terminal Fragment of Bactericidal/Permeability-Increasing Protein in Experimental Endotoxemia. The Journal of Infectious Diseases. 168(5). 1307–1310. 66 indexed citations
15.
Gazzano-Santoro, Hélène, J B Parent, Lynn S. Grinna, et al.. (1992). High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infection and Immunity. 60(11). 4754–4761. 218 indexed citations
16.
17.
Better, Marc & Arnold H. Horwitz. (1989). [33] Expression of engineered antibodies and antibody fragments in microorganisms. Methods in enzymology on CD-ROM/Methods in enzymology. 178. 476–496. 17 indexed citations
18.
Better, Marc, Chun‐Wei Chang, Randy Robinson, & Arnold H. Horwitz. (1988). Escherichia coli Secretion of an Active Chimeric Antibody Fragment. Science. 240(4855). 1041–1043. 441 indexed citations
19.
Horwitz, Arnold H., C. Garrett Miyada, & Gary Wilcox. (1984). Functional limits of the araIc promoter suggest an additional regulatory site for araBAD expression. Journal of Bacteriology. 158(1). 141–147. 7 indexed citations
20.
Horwitz, Arnold H., et al.. (1980). Construction of pBR322-ara hybrid plasmids by in vivo recombination. Molecular and General Genetics MGG. 179(3). 615–625. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael D.P. Boyle Breakdown of academic impact, for papers by Margaret Goodall Breakdown of academic impact, for papers by Ugo D’Oro Breakdown of academic impact, for papers by Roman Halter Breakdown of academic impact, for papers by Toshiko Yamamoto Breakdown of academic impact, for papers by E J Brown Breakdown of academic impact, for papers by Ilka Hoof Breakdown of academic impact, for papers by J P Tite Breakdown of academic impact, for papers by Hélène Gazzano-Santoro Breakdown of academic impact, for papers by J Parkkinen
Rankless by CCL
2026